Adastra Holdings Ltd C.XTRX

Alternate Symbol(s): XTXXF

Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Company’s Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. It partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., Chemia Analytics Inc., 1225140 B.C. Ltd and 1204581 B.C. Ltd.

CSE:XTRX - Post by User

Adastra Holdings Ltd > Adastra Holdings Reports First Quarter Results

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on May 30, 2023 10:28pm

197 Views

Post# 35471526

Adastra Holdings Reports First Quarter Results

Record Q1 2023 gross revenues of $9.5M, increase of 315% from Q1 2022
Record Q1 2023 cash provided by operations of $1.5M, compared to $104K in Q1 2022
Q1 2023 gross profit of $1.7M, increase of 102% from Q1 2022

LANGLEY, BC / ACCESSWIRE / May 30, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the three months ended March 31, 2023.

Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M (accesswire.com)